Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 9, 2026
Medicine · Spain
FLUENZ SUSPENSION PARA PULVERIZACION NASAL
Spray
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- VIRUS INFLUENZA GRIPE REASORTANTE (VIVO ATENUADO) CEPA SIMILAR A A/DARWIN/9/2021 (H3N2) — N/A (vacuna)
- VIRUS INFLUENZA GRIPE REASORTANTE,VIVO, ATENUADO, CEPA SIMILAR A B/ AUSTRIA/1359417/2021 — N/A (vacuna)
- VIRUS INFLUENZA GRIPE, VIVO ATENUADO,REASORTANTE CEPA SIMILAR A A/ VICTORIA/4897/2022 (H1N1) PDM09 — N/A (vacuna)
- Pharmaceutical form Home Med Cabinet grouping
- Spray
- Availability in Spain
- All 2 packs marketed
Packs
FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 1 aplicador nasal
National code
Marketed764648FLUENZ SUSPENSION PARA PULVERIZACION NASAL, 10 aplicadores nasales
National code
Marketed764649
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 1241816001Official data
- Marketing authorisation holder
- ASTRAZENECA ABOfficial data
- Authorised
- Jun 11, 2024Official data
- Authority form code
- 161Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.